Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
Rani Therapeutics (Nasdaq: RANI), a clinical-stage biotherapeutics company specializing in oral delivery of biologics and drugs, has scheduled the release of its fourth quarter and full year 2024 financial results on Monday, March 31, 2025, after market close.
The company will host a conference call and webcast at 4:30 p.m. ET / 1:30 p.m. PT on the same day. Interested parties can access the webcast through the 'Investors' section of Rani's website at www.ranitherapeutics.com. A replay will be available in the investor relations section following the call.
Rani Therapeutics (Nasdaq: RANI), un'azienda bioterapeutica in fase clinica specializzata nella somministrazione orale di biologici e farmaci, ha programmato la pubblicazione dei suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 per lunedì 31 marzo 2025, dopo la chiusura del mercato.
L'azienda organizzerà una conferenza telefonica e un webcast alle 16:30 ET / 13:30 PT lo stesso giorno. Le parti interessate possono accedere al webcast attraverso la sezione 'Investitori' del sito web di Rani all'indirizzo www.ranitherapeutics.com. Una registrazione sarà disponibile nella sezione relazioni con gli investitori dopo la chiamata.
Rani Therapeutics (Nasdaq: RANI), una empresa biofarmacéutica en etapa clínica especializada en la administración oral de biológicos y medicamentos, ha programado la publicación de sus resultados financieros del cuarto trimestre y del año completo 2024 para el lunes 31 de marzo de 2025, después del cierre del mercado.
La empresa llevará a cabo una conferencia telefónica y un webcast a las 4:30 p.m. ET / 1:30 p.m. PT el mismo día. Las partes interesadas pueden acceder al webcast a través de la sección 'Inversores' del sitio web de Rani en www.ranitherapeutics.com. Una repetición estará disponible en la sección de relaciones con inversores después de la llamada.
라니 테라퓨틱스 (Nasdaq: RANI)는 생물학적 제제 및 약물의 경구 전달을 전문으로 하는 임상 단계의 생물 치료 회사로, 2024년 4분기 및 연간 재무 결과를 2025년 3월 31일 월요일, 시장 마감 후 발표할 예정입니다.
회사는 같은 날 오후 4시 30분 ET / 오후 1시 30분 PT에 전화 회의 및 웹캐스트를 개최합니다. 관심 있는 분들은 Rani의 웹사이트 www.ranitherapeutics.com의 '투자자' 섹션을 통해 웹캐스트에 접속할 수 있습니다. 통화 후 투자자 관계 섹션에서 재생이 가능합니다.
Rani Therapeutics (Nasdaq: RANI), une entreprise biopharmaceutique en phase clinique spécialisée dans l'administration orale de biologiques et de médicaments, a prévu la publication de ses résultats financiers du quatrième trimestre et de l'année 2024 pour le lundi 31 mars 2025, après la fermeture du marché.
L'entreprise organisera une conférence téléphonique et un webcast à 16h30 ET / 13h30 PT le même jour. Les parties intéressées peuvent accéder au webcast via la section 'Investisseurs' du site web de Rani à l'adresse www.ranitherapeutics.com. Un enregistrement sera disponible dans la section des relations avec les investisseurs après l'appel.
Rani Therapeutics (Nasdaq: RANI), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf die orale Verabreichung von Biologika und Arzneimitteln spezialisiert hat, hat die Veröffentlichung seiner Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 für Montag, den 31. März 2025, nach Börsenschluss angesetzt.
Das Unternehmen wird am selben Tag um 16:30 Uhr ET / 13:30 Uhr PT eine Telefonkonferenz und einen Webcast veranstalten. Interessierte Parteien können über den Bereich 'Investoren' auf der Website von Rani unter www.ranitherapeutics.com auf den Webcast zugreifen. Eine Aufzeichnung wird nach dem Anruf im Bereich Investor Relations verfügbar sein.
- None.
- None.
SAN JOSE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it plans to release financial results for the fourth quarter and full year ended December 31, 2024 and provide a business update on Monday, March 31, 2025 after the close of trading. Rani’s management team will host a conference call and webcast beginning at 4:30 p.m. ET.
Conference Call and Webcast
Rani Therapeutics will host a conference call and live webcast at 4:30 p.m. ET / 1:30 p.m. PT on March 31, 2025. Individuals interested in listening to the live conference call may do so by using the webcast link in the “Investors” section of the company’s website at www.ranitherapeutics.com. A webcast replay will be available in the investor relations section on the company’s website following the completion of the call.
About Rani Therapeutics
Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. Rani has developed the RaniPill® capsule, which is a novel, proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using RaniPill® capsule technology. For more information, visit ranitherapeutics.com.
Investor Contact:
investors@ranitherapeutics.com
Media Contact:
media@ranitherapeutics.com
FAQ
When will Rani Therapeutics (RANI) release Q4 and full year 2024 earnings?
What time is Rani Therapeutics (RANI) Q4 2024 earnings call?
How can investors access Rani Therapeutics (RANI) Q4 2024 earnings call?
What is Rani Therapeutics' (RANI) main business focus?
